Patent · US Active

Crystalline forms of a potent HCV inhibitor

US8232293B2 · kind B2 · utility

5Cited by

4References

13Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thilo Berkenbusch · Worms, DE
Carl Alan Busacca · Poughkeepsie, US
Burkhard Jaeger · Bingen, DE
Richard J. Varsolona · Scotch Plains, US

Key dates

Filing date	Sep 15, 2009
Grant date	Jul 31, 2012
Priority date	—
Expiry date	Sep 26, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel crystalline forms of the following Compound (1), and the sodium salt thereof, and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.